Technology
Health
Biotechnology

iBio

$0.7211
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.0411 (6.04%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell iBio and other stocks, options, ETFs, and crypto commission-free!

About IBIO

iBio, Inc., also called iBio, is a biotechnology company, which engages in the development and manufacture of biotherapeutics. Its pipeline include idiopathic pulmonary fibrosis, systemic sclerosis, and scleroderma. Read More It operates through the iBio, Inc. and iBio CDMO business segments. The company was founded on April 15, 1993 and is headquartered in New York, NY.

Employees
8
Headquarters
New York, New York
Founded
1993
Market Cap
13.33M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
89.34K
High Today
$0.7079
Low Today
$0.702
Open Price
$0.7034
Volume
13.89K
52 Week High
$1.10
52 Week Low
$0.495

Collections

Technology
Health
Biotechnology
US
North America
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.